well sort fda latest report ssris suicide yields different figures found researchers fda sample finds risk suicidality suicidal preparation actions ssri versus placebo increased non statistically significant degree odds ratio yielding p value analysis finds suicide risk measured suicidal thoughts worse see table fda report actually decreased nonsignificant degree ssris compared placebo p case closed eh evidence increased suicide let go play golf well quite fda find enhanced risk suicidality among individuals age found protective effect medication among elderly see tables starting page much analysis especially placed context prior research based analysis fda database trials khan et al estimated risk completed suicide twice high participants took antidepressants versus took placebos healy noted suicides classified occurring placebo trials actually occurred placebo washout phase participants receiving placebo since nobody time receiving antidepressant medication counting placebo washout events occurring placebo justified healy eliminated suicide suicidal acts occurred placebo washout calculations determined rate completed suicides ssris compared placebo higher odds ratio ci odds ratio suicidal ssri versus placebo ci readers unfamiliar odds ratio means please see slightly advanced treatment topic see longer post meta analyses clinical trials comparing ssris placebo found please go suffice say consistently found elevated risk suicidal acts risk completed suicide ssri compared placebo discussion problems related fda method data collection fda data differs rather widely found another analysis fda study based upon reports sponsors thus drug companies trusted provide data honest fashion given cases paroxetine sertraline fluoxetine sponsors misleadingly labeled placebo washout suicidal acts occurring double blind placebo phase issue i certain happened current fda report ruled possibility i never sold fda data i doubt data released manner would allow determination suicidal events happened selected clinical trials i strongly encourage readers examine table fda report page compare healy figures table document rate suicidal acts placebo much higher fda database compared healy database addition rate ssris citalopram escitalopram fluoxetine fluvoxamine paroxetine sertraline healy database versus fda database comparison healy fda risk placebo much less ssris yes clear fda database contained larger sample trials healy earlier analysis however equally clear data healy database likely trustworthy able sort placebo versus placebo washout whereas fda relied sponsors sorting data healy study also appears utilized uncontrolled trials active comparator controlled trials trials medication compared another medication placebo whereas fda numbers based placebo controlled trials yes i understand different samples studies important note large differences terms results let also forget mhra roughly equivalent usa fda analysis found use ssris even excluding paroxetine seems related greatly elevated risk suicidal behavior relative placebo see increased risk suicidality said people better informed myself next days i hope keep everyone apprised fda others say publicly findings hearing scheduled two days dec forthcoming soon